• info@arocell.com
  • +46 (0)18 50 30 20
  • English
  • Svenska
Arocell TK 210 ELISA
  • about
    • A word from the CEO
    • Vision and mission
    • Strategy and goals
    • Board of Directors
    • Management
    • Partnership
    • Company history
    • Policies
  • product
    • AroCell TK 210 ELISA
    • Why measure Thymidine Kinase 1?
    • Performance and technical specifications
    • Instructions for use
  • applications
    • Drug discovery and development
    • Clinical cancer research
    • Clinical studies
    • Scientific references
    • Posters and presentations
  • technologies
    • Thymidine Kinase 1
    • Patent portfolio
    • Scientific references
    • Posters and presentations
  • news & media
    • News
    • Press releases
    • Events
  • investors
    • AroCell – Company overview
    • The share
    • Financial report
    • Analyst coverage
    • Share issues
    • Press releases
    • Financial presentations
    • Financial calendar
    • Annual General Meeting
    • Governance
    • Certified advisor
    • Investor relations contact
  • contact & order
    • Contact
    • Distributors
    • Service
    • Order
    • Q & A
Menu
  • about
    • A word from the CEO
    • Vision and mission
    • Strategy and goals
    • Board of Directors
    • Management
    • Partnership
    • Company history
    • Policies
  • product
    • AroCell TK 210 ELISA
    • Why measure Thymidine Kinase 1?
    • Performance and technical specifications
    • Instructions for use
  • applications
    • Drug discovery and development
    • Clinical cancer research
      • Hematological malignancies
      • Breast cancer
      • Other solid tumors
    • Clinical studies
    • Scientific references
    • Posters and presentations
  • technologies
    • Thymidine Kinase 1
    • Patent portfolio
    • Scientific references
    • Posters and presentations
  • news & media
    • News
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
    • Press releases
    • Events
  • investors
    • AroCell – Company overview
    • The share
      • Ownership structure
      • Insider trading
    • Financial report
    • Analyst coverage
    • Share issues
      • New share issue 2019
      • Nyemission 2018
      • Listing at First North 2016
      • Nyemission 2015
    • Press releases
    • Financial presentations
    • Financial calendar
    • Annual General Meeting
      • Annual General Meeting 2021
      • Annual General Meeting 2020
      • Annual General Meeting 2019
      • Annual General Meeting 2018
      • Annual general meeting 2017
      • Annual general meeting 2016
      • Annual general meeting 2015
    • Governance
      • Board of Directors
      • Management
      • Articles of association
      • Nomination committee
    • Certified advisor
    • Investor relations contact
  • contact & order
    • Contact
    • Distributors
    • Service
    • Order
    • Q & A
  • AroCell – Company overview
  • The share
    • Ownership structure
    • Insider trading
  • Financial report
  • Analyst coverage
  • Share issues
    • New share issue 2019
    • Nyemission 2018
    • Listing at First North 2016
    • Nyemission 2015
  • Press releases
  • Financial presentations
  • Financial calendar
  • Annual General Meeting
    • Annual General Meeting 2021
    • Annual General Meeting 2020
    • Annual General Meeting 2019
    • Annual General Meeting 2018
    • Annual general meeting 2017
    • Annual general meeting 2016
    • Annual general meeting 2015
  • Governance
    • Board of Directors
    • Management
    • Articles of association
    • Nomination committee
  • Certified advisor
  • Investor relations contact

Investor relations contact

Anders Hultman

Anders Hultman

CEO

Anders.hultman@arocell.com
Tel: +46 (0)18-50 30 20

Subscription for news and press releases

  • about
    • A word from the CEO
    • Vision and mission
    • Strategy and goals
    • Board of Directors
    • Management
    • Partnership
    • Company history
    • Policies
  • product
    • AroCell TK 210 ELISA
    • Why measure Thymidine Kinase 1?
    • Performance and technical specifications
    • Instructions for use
  • applications
    • Drug discovery and development
    • Clinical cancer research
      • Hematological malignancies
      • Breast cancer
      • Other solid tumors
    • Clinical studies
    • Scientific references
    • Posters and presentations
  • technologies
    • Thymidine Kinase 1
    • Patent portfolio
    • Scientific references
    • Posters and presentations
  • news & media
    • News
    • Press releases
    • Events
  • investors
    • AroCell – Company overview
    • The share
      • Ownership structure
      • Insider trading
    • Financial report
    • Analyst coverage
    • Share issues
      • New share issue 2019
      • Nyemission 2018
      • Listing at First North 2016
      • Nyemission 2015
    • Press releases
    • Financial presentations
    • Financial calendar
    • Annual General Meeting
      • Annual General Meeting 2021
      • Annual General Meeting 2020
      • Annual General Meeting 2019
      • Annual General Meeting 2018
      • Annual general meeting 2017
      • Annual general meeting 2016
      • Annual general meeting 2015
    • Governance
      • Board of Directors
      • Management
      • Articles of association
      • Nomination committee
    • Certified advisor
    • Investor relations contact
  • contact & order
    • Contact
    • Distributors
    • Service
    • Order
    • Q & A
  • English
  • Svenska
AroCell AB Uppsala Business Park
Virdings allé 32 B
SE-754 50 Uppsala Sweden
  • info@arocell.com
  • +46 (0)18 50 30 20

POLICIES

All of the information appearing on this website is not intended to be used for medical diagnosis or treatment. Information provided on this website does not either constitute medical and/or other professional advice. AroCell TK 210 ELISA is CE-marked and registered by the Swedish Medical Products Agency.

We use cookies to improve the user experience and gather anonymous visitor statistics. By using our website, you agree to the use of cookies.

I agree.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of the cookies.
SettingsAccept
Manage consent

Overview

Cookies are a file that is sent from our server and stored in your browser. We use cookies to improve the user experience and to collect anonymous visitor statistics. You can control the use of cookies via settings in your browser, but keep in mind that some services may not work as expected if you block or delete cookies.
Necessary Cookies
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

SAVE & ACCEPT